About
Inhibitors against respiratory viral infections
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
299
By Phase
PHASE1: 2PHASE2: 1
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05555823Lead Sponsor
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Food Effect and DDI of Ascending Doses of the MEK Inhibitor Zapnometinib
PHASE1Completed
96 participants
Started: Jun 23, 2022 · Completed: Jul 20, 2023
NCT04776044Lead Sponsor
Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19
PHASE2Terminated
133 participants
Started: Apr 12, 2021 · Completed: Aug 9, 2022
NCT04385420Lead Sponsor
Phase 1 Study of ATR-002
PHASE1Completed
70 participants
Started: Apr 24, 2019 · Completed: Aug 26, 2019
Locations (1)
Headquarters
Planegg, Germany
Map
Loading map...